Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?

    ... (MDS) characterized by poor-risk or intermediate-risk cytogenetics , who have a histocompatible related or unrelated donor ...

    Research Article last updated 11/16/2011 - 2:15pm.

  2. Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.

    ... of chromosomal defects undetected by metaphase cytogenetics (MC) in hematologic cancers, offering superior resolution of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Prognosis of myelodysplastic syndromes.

    ... characteristics such as peripheral cytopenias and cytogenetics . The International Prognostic Scoring System (IPSS) ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Unraveling the molecular pathophysiology of myelodysplastic syndromes.

    ... focal alterations that are not apparent by standard cytogenetics , and aberrant epigenetic regulation of gene expression. The ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes.

    ... with azacitidine. Each patient, one with normal cytogenetics at relapse; one with a 18 abnormality; and one with ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Prognostic classification and risk assessment in myelodysplastic syndromes.

    ... for the World Health Organization (WHO) categories, cytogenetics , transfusion dependency, and bone marrow fibrosis ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant

    ... survival was reduced in patients with high-risk cytogenetics (p = 0.02), Karnofsky performance status ≤ 80% (p = 0.001) ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine.

    ... Performance status ≥ 2, intermediate- and poor-risk cytogenetics , presence of circulating blasts, and red blood cell ...

    Research Article last updated 07/28/2014 - 8:53am.

  9. Perceptions of Disease State, Treatment Outcomes, and Prognosis Among Patients with Myelodysplastic Syndromes: Results From an Internet-Based Survey.

    ... of their blast percentage, and 28% were unaware of their cytogenetics . Patients were unlikely to recall having their MDS described ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. Transplantation for myelodysplastic syndromes 2013.

    ... relapse-free survival even in patients with high-risk cytogenetics . The optimal stem cell source may differ for different patient ...

    Research Article last updated 10/22/2013 - 12:53pm.